Skip to main content
Clinical Trials/IRCT20200128046288N5
IRCT20200128046288N5Not yet recruitingPhase 2

Clinical evaluation of the effect of Jadwar (Delphinium denudatum) capsules on quality of life and fatigue of multiple sclerosis patients

Ahvaz University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 65 years (—)
Sex
All

Inclusion Criteria

  • MS has been proven by clinical examinations and medical history
  • Having stable and regular drug treatment in the last 4 weeks
  • No new attack in last month
  • Having a score of EDSS disability assessment between 2 to 5.5

Exclusion Criteria

  • Pregnancy and lactation
  • Renal and hepatic dysfunction
  • Neurologic disease in addition to MS
  • Cardiovascular disease or infectious disease
  • Allergy to Jadwar

Investigators

Similar Trials